About

Thomas Dorlo is a pharmacometrician and clinical pharmacology expert. His research interests include neglected tropical diseases, international health, and anything related to modeling of pharmacokinetics (PK) and pharmacodynamics (PD).

He is leading a group that focuses on clinical pharmacology, bioanalysis, biomarker evaluation, and modeling and simulation of PK and PD, for parasitic poverty-related diseases such as leishmaniasis (both cutaneous and visceral) and malaria. He co-leads the pharmacometrics group at the NKI, supervising PhD students working on applied pharmacometrics in oncology and maintaining the high-performance computing resources. His research is particularly focused on optimization of drug therapy in vulnerable populations, such as pregnant women and children. His work is supported by a Veni fellowship from the Netherlands Organisation for Scientific Research (NWO) and various EDCTP grants.

Thomas is also a board member of the Dutch Society against Quackery and publishes regularly on non-scientific alternative medicine, such as homeopathy and traditional medicine.